Skip to main content
Supervisor
Daiga Behmane

Study Course Description

Course Description Statuss:Approved
Course Description Version:1.00
Study Course Information
Course Code:VVDG_008LQF level:Level 7
Credit Points:2.00ECTS:3.00
Branch of Science:Pharmacognosy; Social PharmacyTarget Audience:Health Management
Study Course Supervisor
Course Supervisor:Daiga Behmane
Study Course Implementer
Structural Unit:Health Management Teaching Staff Group
The Head of Structural Unit:Daiga Behmane
Contacts:Rīga, Dzirciema iela 16, vvdgatrsu[pnkts]lv, vvdgatrsu[pnkts]lv, +371 67409855
Study Course Planning
Full-Time - 1. Semester No.
Lectures (number)6Lecture Length (academic hours)2Total Contact Hours of Lectures12
Classes (number)6Class Length (academic hours)2Total Contact Hours of Classes12
Total Contact Hours24
Study course description
Preliminary Knowledge:
none
Objective:
The course provides students with a broad oversight of the theoretical and practical aspects of contemporary pharmaceutical markets and systems: their design, functions and objectives as well as major current issues in the development of national pharmaceutical policies and reforms.
Topic Layout (Full-Time)
No.TopicType of ImplementationNumberVenue
1Lectures2.00auditorium
2Classes2.00auditorium
3Lectures2.00auditorium
4Classes2.00auditorium
5Lectures2.00auditorium
6Classes2.00auditorium
7Lectures2.00auditorium
8Classes2.00auditorium
9Lectures2.00auditorium
10Classes2.00auditorium
11Lectures2.00auditorium
12Classes2.00auditorium
Assessment
Unaided Work:
- Published research and study literature and health policy document reading and analysis; - Development and presentation of the individual and group class work.
Assessment Criteria:
- Activity during interactive lectures; - Quality and terms of individual and group tasks.
Final Examination (Full-Time):Test
Final Examination (Part-Time):
Learning Outcomes
Knowledge:Upon successful completion of the course the students will: - Describe pharmaceutical markets, elements and interaction between stakeholders; - Define pharmaceutical regulation systems, their functions and objectives; - Describe the elements and governance of pharmaceutical systems; - Describe the goals and principles of pharmaceutical reimbursemnet systems; - Describe the cost containment measures and the role of economic evaluation.
Skills:The students learn how to: - Analyse the performance of pharmaceutical market and the role of different stakeholders; - Describe and compare the pharmaceutical system performance indicators; - Explain the goals of pharmaceutical policy and the objectives of government regulation.
Competencies:Students will be able to: - Perform comparative analysis of pharmaceutical markets and systems; - Link different policy recommendations to specific system outcomes; - Recognize the importance of cost-containment measures in the regulation of of pharmaceuticals to support health system objectives.
Bibliography
No.Reference
1E.Mossialos, M.Mrazek, T.Walley „Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality, European Observatory n Health Systems and Policies, 2004, www.euro.who.int/document/e83015.pdf
2Drugs and money: Prices, affordability and cost containment, 7th edition, 2003, WHO; http://apps.who.int/medicinedocs/en/d/Js4912e/
1Priority Medicines for Europe and the World update Report, 2013, http://www.who.int/medicines/areas/priority_medicines/en
1http://ec.europa.eu/enterprise/sectors/pharmaceuticals/
2www.who.int/medicines/
3http://whocc.goeg.at